274 related articles for article (PubMed ID: 30504630)
1. 2-Acyl-3-carboxyl-tetrahydroisoquinoline Derivatives: Mixed-Type PTP1B Inhibitors without PPARγ Activation.
Morishita K; Shoji Y; Fukui M; Ito Y; Kitao T; Ozawa SI; Hirono S; Shirahase H
Chem Pharm Bull (Tokyo); 2018; 66(12):1131-1152. PubMed ID: 30504630
[TBL] [Abstract][Full Text] [Related]
2. Novel 2,7-Substituted (S)-1,2,3,4-Tetrahydroisoquinoline-3-carboxylic Acids: Peroxisome Proliferator-Activated Receptor γ Partial Agonists with Protein-Tyrosine Phosphatase 1B Inhibition.
Otake K; Azukizawa S; Takeda S; Fukui M; Kawahara A; Kitao T; Shirahase H
Chem Pharm Bull (Tokyo); 2015; 63(12):998-1014. PubMed ID: 26633022
[TBL] [Abstract][Full Text] [Related]
3. Novel Non-carboxylate Benzoylsulfonamide-Based Protein Tyrosine Phosphatase 1B Inhibitors with Non-competitive Actions.
Morishita K; Shoji Y; Tanaka S; Fukui M; Ito Y; Kitao T; Ozawa SI; Hirono S; Shirahase H
Chem Pharm Bull (Tokyo); 2017; 65(12):1144-1160. PubMed ID: 29199219
[TBL] [Abstract][Full Text] [Related]
4. 2-Acyl-tetrahydroisoquinoline-3-carboxylic acids: lead compounds with triple actions, peroxisome proliferator-activated receptor α/γ agonist and protein-tyrosine phosphatase 1B inhibitory activities.
Otake K; Azukizawa S; Takahashi K; Fukui M; Shibabayashi M; Kamemoto H; Kasai M; Shirahase H
Chem Pharm Bull (Tokyo); 2011; 59(7):876-9. PubMed ID: 21720040
[TBL] [Abstract][Full Text] [Related]
5. (S)-1,2,3,4-Tetrahydroisoquinoline Derivatives Substituted with an Acidic Group at the 6-Position as a Selective Peroxisome Proliferator-Activated Receptor γ Partial Agonist.
Morishita K; Miike T; Takeda S; Fukui M; Ito Y; Kitao T; Ozawa SI; Hirono S; Shirahase H
Chem Pharm Bull (Tokyo); 2019; 67(11):1211-1224. PubMed ID: 31685749
[TBL] [Abstract][Full Text] [Related]
6. Novel (S)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids: peroxisome proliferator-activated receptor γ selective agonists with protein-tyrosine phosphatase 1B inhibition.
Otake K; Azukizawa S; Fukui M; Kunishiro K; Kamemoto H; Kanda M; Miike T; Kasai M; Shirahase H
Bioorg Med Chem; 2012 Jan; 20(2):1060-75. PubMed ID: 22197396
[TBL] [Abstract][Full Text] [Related]
7. A novel series of (S)-2,7-substituted-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids: peroxisome proliferator-activated receptor α/γ dual agonists with protein-tyrosine phosphatase 1B inhibitory activity.
Otake K; Azukizawa S; Fukui M; Shibabayashi M; Kamemoto H; Miike T; Kunishiro K; Kasai M; Shirahase H
Chem Pharm Bull (Tokyo); 2011; 59(10):1233-42. PubMed ID: 21963632
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and Evaluation of a Novel Series of 2,7-Substituted-6-tetrazolyl-1,2,3,4-tetrahydroisoquinoline Derivatives as Selective Peroxisome Proliferator-Activated Receptor γ Partial Agonists.
Morishita K; Ito Y; Otake K; Takahashi K; Yamamoto M; Kitao T; Ozawa SI; Hirono S; Shirahase H
Chem Pharm Bull (Tokyo); 2021; 69(4):333-351. PubMed ID: 33790079
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic effects of the allosteric protein tyrosine phosphatase 1B inhibitor KY-226 on experimental diabetes and obesity via enhancements in insulin and leptin signaling in mice.
Ito Y; Fukui M; Kanda M; Morishita K; Shoji Y; Kitao T; Hinoi E; Shirahase H
J Pharmacol Sci; 2018 May; 137(1):38-46. PubMed ID: 29731242
[TBL] [Abstract][Full Text] [Related]
10. Hypoglycemic effect and mechanism of honokiol on type 2 diabetic mice.
Sun J; Fu X; Liu Y; Wang Y; Huo B; Guo Y; Gao X; Li W; Hu X
Drug Des Devel Ther; 2015; 9():6327-42. PubMed ID: 26674084
[TBL] [Abstract][Full Text] [Related]
11. Discovery of novel bromophenol 3,4-dibromo-5-(2-bromo-3,4-dihydroxy-6-(isobutoxymethyl)benzyl)benzene-1,2-diol as protein tyrosine phosphatase 1B inhibitor and its anti-diabetic properties in C57BL/KsJ-db/db mice.
Jiang B; Guo S; Shi D; Guo C; Wang T
Eur J Med Chem; 2013 Jun; 64():129-36. PubMed ID: 23644196
[TBL] [Abstract][Full Text] [Related]
12. Docking Assisted Prediction and Biological Evaluation of Sideritis L. Components with PTP1b Inhibitory Action and Probable Anti-Diabetic Properties.
Eleftheriou P; Therianou E; Lazari D; Dirnali S; Micha A
Curr Top Med Chem; 2019; 19(5):383-392. PubMed ID: 30806317
[TBL] [Abstract][Full Text] [Related]
13. A Library of Thiazolidin-4-one Derivatives as Protein Tyrosine Phosphatase 1B (PTP1B) Inhibitors: An Attempt To Discover Novel Antidiabetic Agents.
Patel AD; Pasha TY; Lunagariya P; Shah U; Bhambharoliya T; Tripathi RKP
ChemMedChem; 2020 Jul; 15(13):1229-1242. PubMed ID: 32390300
[TBL] [Abstract][Full Text] [Related]
14. α-Methyl artoflavanocoumarin from Juniperus chinensis exerts anti-diabetic effects by inhibiting PTP1B and activating the PI3K/Akt signaling pathway in insulin-resistant HepG2 cells.
Jung HJ; Seong SH; Ali MY; Min BS; Jung HA; Choi JS
Arch Pharm Res; 2017 Dec; 40(12):1403-1413. PubMed ID: 29177868
[TBL] [Abstract][Full Text] [Related]
15. PTP1b Inhibition, A Promising Approach for the Treatment of Diabetes Type II.
Eleftheriou P; Geronikaki A; Petrou A
Curr Top Med Chem; 2019; 19(4):246-263. PubMed ID: 30714526
[TBL] [Abstract][Full Text] [Related]
16. Discovery of 5-(3-bromo-2-(2,3-dibromo-4,5-dimethoxybenzyl)-4,5-dimethoxybenzylidene)thiazolidine-2,4-dione as a novel potent protein tyrosine phosphatase 1B inhibitor with antidiabetic properties.
Jiang B; Luo J; Guo S; Wang L
Bioorg Chem; 2021 Mar; 108():104648. PubMed ID: 33493928
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of some tetrazole acetamide derivatives as novel non-carboxylic PTP1B inhibitors.
Maheshwari N; Karthikeyan C; Bhadada SV; Verma AK; Sahi C; Moorthy NSHN; Trivedi P
Bioorg Chem; 2019 Nov; 92():103221. PubMed ID: 31499261
[TBL] [Abstract][Full Text] [Related]
18. Thiazolidinedione derivatives as PTP1B inhibitors with antihyperglycemic and antiobesity effects.
Bhattarai BR; Kafle B; Hwang JS; Khadka D; Lee SM; Kang JS; Ham SW; Han IO; Park H; Cho H
Bioorg Med Chem Lett; 2009 Nov; 19(21):6161-5. PubMed ID: 19783142
[TBL] [Abstract][Full Text] [Related]
19. Trivaric acid, a new inhibitor of PTP1b with potent beneficial effect on diabetes.
Sun W; Zhang B; Zheng H; Zhuang C; Li X; Lu X; Quan C; Dong Y; Zheng Z; Xiu Z
Life Sci; 2017 Jan; 169():52-64. PubMed ID: 27871946
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, SAR and docking studies of substituted aryl phenylthiazolyl phenylcarboxamide as potential protein tyrosine phosphatase 1B (PTP1B) inhibitors.
Varshney K; Gupta AK; Rawat A; Srivastava R; Mishra A; Saxena M; Srivastava AK; Jain S; Saxena AK
Chem Biol Drug Des; 2019 Jul; 94(1):1378-1389. PubMed ID: 30903642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
